Vanderbilt-Ingram Cancer Center
Why trials sponsored by Vanderbilt-Ingram Cancer Center stopped, in this sample of ClinicalTrials.gov.
19 stopped trials with a clear reason; 95% ended for non-scientific reasons.
| Reason | Trials | Share |
|---|---|---|
| slow accrual | 13 | 68% |
| funding business | 4 | 21% |
| logistics pi | 1 | 5% |
| futility | 1 | 5% |
Where it ranks
- #5 of 90 sponsors by share of trials stopped for: slow accrual (68%).
Among ranked sponsors in this sample. Shares of stopped trials, not failure rates. See all scorecards.
Trials
- Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma
NCT03558750 · TERMINATED · slow accrual
“Low accrual” - Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma
NCT03000179 · TERMINATED · slow accrual
“Low accrual” - Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers
NCT02440737 · TERMINATED · slow accrual
“Slow accrual” - Quantitative MRI in Assessing Disease in Patients With Brain Tumors
NCT02269111 · TERMINATED · funding business
“Change in PI and funding” - Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant
NCT02240381 · TERMINATED · funding business
“Funding expired” - Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)
NCT02151539 · TERMINATED · slow accrual
“Low accrual” - 3-Tesla MRI Response to TACE in HCC (Liver Cancer)
NCT02057874 · TERMINATED · funding business
“Funding unavailable” - FDG-PET in Advanced Melanoma
NCT02236546 · TERMINATED · funding business
“loss of funding” - Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma
NCT01316692 · TERMINATED · slow accrual
“low accrual” - Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis
NCT01324908 · TERMINATED · slow accrual
“Low accrual” - PET/CT Evaluation of Treatment Response in Breast Cancer
NCT01222416 · TERMINATED · slow accrual
“Slow accrual” - Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel
NCT01096407 · TERMINATED · slow accrual
“slow accrual” - Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery
NCT00984490 · TERMINATED · slow accrual
“slow accrual” - Internet-Based Clinical Information and Blood Sample Collection From Patients With Non-Small Cell Lung Cancer Who Never Smoked Cigarettes
NCT01141218 · TERMINATED · slow accrual
“slow accrual” - Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer
NCT00892801 · TERMINATED · slow accrual
“Terminated due to low accrual. Study was closed to accrual prematurely and did not continue on to Phase II.” - Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
NCT00949052 · TERMINATED · slow accrual
“Low accrual” - Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan
NCT00602147 · TERMINATED · logistics pi
“The original PI on this study left VICC, thus study was closed.” - Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil
NCT00608517 · TERMINATED · slow accrual
“slow accrual” - Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma
NCT00512798 · TERMINATED · futility
“This study was terminated due to lack of efficacy”
Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.